ATS 2024 Final Program

Click on the session title to view the speakers

294

TUESDAY • MAY 21

2:15 Session Introduction 2:20 Social Determinants of Health in Pediatric Lung Diseases 2:35 Structural Neighborhood and Environmental Factors Contributing to Disparities 2:50 How the Healthcare System Creates Disparities 3:05 Disparities Down To Epigenetics and Beyond 3:20 Where Do We Go Next? Achieving Health Equity in all Pediatric Pulmonary Diseases 3:40 A Call For Action To Achieve Health Equity

phenotype in neonates and children. A number of basic studies are based on being able to better identify patient populations and understand disease severity. This session will focus on tools to help researchers with the same. We will demonstrate how advanced machine learning has been used in pulmonary disease such as asthma and BPD. 2:15 Discovering Pediatric Asthma Phenotypes Using Machine Learning 2:35 Developing Artificial Intelligence Technology For Pediatric Pulmonology: Lessons from COVID-19. 2:55 Machine Learning in BPD 3:15 Innovations in Health Information Technologies for Chronic Pulmonary Diseases 3:35 Discussion BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM C88 HEALTH EQUITY ACROSS PEDIATRIC PULMONARY DISEASES Assembly on Pediatrics 2:15 P.M. - 3:45 P.M. San Diego Convention Center Room 6C-F (Upper Level)s Target Audience Providers of pediatric lung health, all health equity researchers Objectives At the conclusion of this session, the participant will be able to: • describe how a wide range of factors (social, environmental, healthcare, genetic) contribute to health disparities in patient outcomes in pediatric pulmonary diseases, such as BPD, CF, asthma, sickle cell disease • integrate new guidelines on using race and ethnicity in PFTs into clinical practice and research • improve patients’ outcomes and quality of life by addressing factors known to contribute to health disparities in pediatric pulmonary diseases Health disparities exist across many pulmonary diseases occurring in children. Speakers will address the latest health disparities research and how we move to equity for all pediatric lung diseases. This will discuss social determinants of health, structural and environmental factors, healthcare system, and biological factors contributing to disparities in many pediatric lung diseases.

BASIC • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM

C89 HIV-RELATED LUNG DISEASE:

UPDATES IN PATHOPHYSIOLOGY, CLINICAL TRIALS AND FUTURE DIRECTIONS

Assemblies on Pulmonary Infections and Tuberculosis; Allergy, Immunology and Inflammation; Environmental, Occupational and Population Health 2:15 p.m. - 3:45 p.m. San Diego Convention Center Room 30A-B (Upper Level) Target Audience Providers of lung health, particularly those who provide clinical care for people living with HIV; basic , clinical and translational researchers with a focus on HIV-related lung disease; global health agencies and stakeholders Objectives At the conclusion of this session, the participant will be able to: • understand the epidemiology of HIV-related lung disease across the spectrum of high and low/middle-income countries and how these differences may impact priorities for research and practice in improving the lung health of people living with HIV • integrate recent findings related to the pathophysiology and management of HIV-related lung disease • apply specific recommendations unique to providing care to improve the lung health of people living with HIV Lung disease is one of the most important and prevalent complications of HIV. This session will provide updates on the: 1)

ATS 2024 Conference Program • San Diego, CA